Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Chemotherapy suffers numbers of limitations including poor drug solubility, nonspecific biodistribution, and inevitable adverse effects on normal tissues. Tumor‐targeted delivery and intratumoral stimuli‐responsive release of drugs by nanomedicines are considered to be highly promising in solving these problems. Compared with traditional chemotherapeutic drugs, high concentration of nitric oxide (NO) exhibits unique anticancer effects. The development of tumor‐targeting and intratumoral microenvironment‐responsive NO‐releasing nanomedicines is highly desired. Here a novel kind of organic–inorganic composite nanomedicine (QM‐NPQ@PDHNs) is presented by encapsulating a glutathione S‐transferases π (GSTπ)‐responsive drug O2‐(2,4‐dinitro‐5‐{[2‐(β‐d‐galactopyranosyl olean‐12‐en‐28‐oate‐3‐yl)‐oxy‐2‐oxoethyl] piperazine‐1‐yl} phenyl) 1‐(methylethanolamino)diazen‐1‐ium‐1,2‐dilate (NPQ) as NO donor and an aggregation‐induced‐emission (AIE) red fluorogen QM‐2 into the cores of the hybrid nanomicelles (PEGylated disulfide‐doped hybrid nanocarriers (PDHNs)) with glutathione (GSH)‐responsive shells. The QM‐NPQ@PDHN nanomedicine is able to respond to the intratumoral over‐expressed GSH and GSTπ, resulting in the responsive biodegradation of the protective organosilica shell and NPQ release, and subsequent NO release within the tumor, respectively, and thus normal organs remain unaffected. This work demonstrates a paradigm of dual intratumoral redox/enzyme‐responsive NO‐release nanomedicine for tumor‐specific and high‐efficacy cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This makes glutathione an excellent target for drug delivery in cancer therapy [211,212,213,214,215].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [215]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
Advanced drug delivery devices via self-assembly of amphiphilic block copolymers
Rösler, A., Vandermeulen, G. W. M., & Klok, H.-A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.026 · Cited by 688
Hu, X., Hu, J., Tian, J., Ge, Z., Zhang, G., Luo, K., & Liu, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409686x · Cited by 605
Drug self-delivery systems for cancer therapy
Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532
Research works printed but not linked: 1
- Matsumura Y., 1986, Cancer Res., 46, 6387
Cited by
Items 201–232 of 232
Manganese single-atom nanostructures for highly efficient tumor therapy
Pei, J., Dou, H., Liu, C., & Li, T. (2022) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2022.02.016 · Cited by 6
Spatio‐Temporally Reporting Dose‐Dependent Chemotherapy via Uniting Dual‐Modal MRI/NIR Imaging
Ma, Y., Yan, C., Guo, Z., Tan, G., Niu, D., Li, Y., & Zhu, W. (2020) · Angewandte Chemie · doi:10.1002/ange.202009380 · Cited by 7
Self-citationHan, L., Huang, Z., Zhu, Y., & Li, H. (2022) · Ceramics International · doi:10.1016/j.ceramint.2022.12.161 · Cited by 6
Self-citationCO2/NIR light dual-controlled nanoparticles for dsDNA unzipping
Wang, Y., Yuan, H., Li, D., & Xing, C. (2019) · Chinese Chemical Letters · doi:10.1016/j.cclet.2019.04.020 · Cited by 6
Self-citationEngineered nanomedicine targets liver cancer stem cells to treat liver cancer disease
Huang, F., Chen, L., Zhang, X., Tian, S., Han, Y., Hu, M., He, L., & Luo, R. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01278c · Cited by 7
Organic nanocarriers for targeted delivery of anticancer agents
Dahiya, S., & Dahiya, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00010-9 · Cited by 4
Zou, J., Jiang, C., Li, X., Zhong, T., Wang, S., Wang, B., Zhang, D., Hao, J., Cao, Y., Guan, M., et al. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101707 · Cited by 3
Self-citationYuan, Y., Hou, M., Song, X., Yao, X., Wang, X., Chen, X., & Li, S. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s464186 · Cited by 5
Shu, J., Dong, X., Zhang, Y., Pan, Z., Lu, T., Kang, S., Liu, Q., Hou, Z., Wang, S., & Yang, B. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.112476 · Cited by 3
Self-citationWang, L., Huang, Y., Yu, Y., Zhong, H., Xiao, H., Zhang, G., & Zhang, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100896 · Cited by 3
Emerging need of advanced drug delivery systems in cancer
Prasher, P., Sharma, M., & Dua, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00032-8 · Cited by 3
Hao, Y., Li, H., Ge, X., Liu, Y., Li, X., Liu, Y., Chen, H., Zhang, S., Zou, J., Huang, L., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202214992 · Cited by 2
Shoot the Arrow at the Target: Innovative Stimulus-Responsive Smart Nanocarriers for Cancer TherapyPreprint
Liu, X., He, F., & Liu, M. (2024) · Preprints.org · doi:10.20944/preprints202401.2225.v1 · Cited by 2
Sun, T., Li, C., Li, X., Song, H., Su, B., You, H., Zhang, T., & Jiang, C. (2022) · Micro/Nano technologies · doi:10.1007/978-981-13-9374-7_10-1 · Cited by 2
Peng, Y., Da, X., Zhou, W., Xu, Y., Liu, X., Yao, W., Wang, X., & Zhou, Q. (2024) · Inorganica Chimica Acta · doi:10.1016/j.ica.2024.122058 · Cited by 2
Fan, C., Xi, Z., Zhou, R., Li, Z. H., Liu, H., Wang, M., Sun, M., & Xu, L. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167453 · Cited by 2
Shuai, L., Xiang, Q., & Dong, H. (2026) · Materials Chemistry Frontiers · doi:10.1039/d6qm00216a · Cited by 1
Ghaemi, N. S., Amiri, M., Moharramnejad, M., Yarahmadi, S., Nabavi, J., Kahvand, M., Shahi, M., & Ehsani, A. (2026) · Polymer Bulletin · doi:10.1007/s00289-026-06613-0 · Cited by 1
Jiang, J., Zhang, T., Dong, J., & Sun, W. (2026) · Advanced Science · doi:10.1002/advs.77450
Gas probes and their application in gas therapy
Gong, W.-J., Yu, Z., & He, Q. (2021) · Chemical Synthesis · doi:10.20517/cs.2021.04 · Cited by 1
Self-citationCheng, L., Zhang, F., Wang, S., Pan, X., Han, S., Liu, S., Ma, J., Wang, H., Shen, H., Liu, H., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201902476 · Cited by 1
Il rischio assicurativo e le nuove figure del danno. Il danno esistenziale
Cendon, P. (2002) · Rassegna parlamentare
Silver Clusters-loaded Silica-based Hybrid Nanoparticles: Synthesis and SERS Performance
Wen, Z., Niu, D., & Yongsheng, L. I. (2021) · Journal of Inorganic Materials · doi:10.15541/jim20210201
Self-citationChen, Z., Wang, L., Jin, Y., Guo, H., Zhang, Y., Ma, M., Wang, X., Zhou, X., Lei, Z., & Lu, D. (2023) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2023.105565
Self-citationRecent progress in multi-functional conjugated polymers in the diagnosis and treatment of diseases
Li, L., & Tang, Y. (2024) · Scientia Sinica Chimica · doi:10.1360/ssc-2024-0106
Zhang, X., Hu, J., Becker, K. V., Engle, J. W., Ni, D., Cai, W., Wu, D., & Qu, S. (2021) · Figshare · doi:10.6084/m9.figshare.14429449
Efficient discovery of anticancer peptides via cost-aware ranking learningPreprint
Wang, Y., Yue, J., Xu, J., Chen, Z., Li, T., Tang, Z., Li, X., Tan, H., Xiang, W., & Liu, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-8539436/v1 · Cited by 1
Self-citationHuang, M., Wang, K. X., Gao, R., Shao, Q., Liu, Y. L., Li, F., & Li, L. (2026) · Small · doi:10.1002/smll.74605
Li, Q., Y, Z., He, M., Shi, S. Q., Zhang, L., Li, Y., Xu, Z., Yang, X., Pan, Y., Fan, J., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71458
Self-citationZou, J., Leng, Y., Zhang, C., Zhang, C., Shi, L., Chen, P., Jiang, C., Liu, Y., Zhang, D., Huang, Z., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c13896
Self-citationLi, R., Chang, R., Chen, Z., Li, B., Chen, K., Liu, X., Liu, Y., & Gao, S. (2026) · Research Square · doi:10.21203/rs.3.rs-11202442/v1
Yao, J., Zhang, X., Liu, X., Liu, Z., Wang, F., Zhang, L., Yu, Y., Yan, C., & Xu, H. (2026) · Nanoscale Horizons · doi:10.1039/d6nh00326e
Metadata
- Authors
- Jia, X., Zhang, Y., Zou, Y., Wang, Y., Niu, D., He, Q., Huang, Z., Zhu, W., Tian, H., Shi, J., & Li, Y.
- Affiliations
- East China University of Science and Technology (CN)
- China Pharmaceutical University (CN)
- Shenzhen University (CN)
- Corresponding author
- Huang, Zhangjian
- Li, Yongsheng
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2018-06-11
- Volume
- 30
- Issue
- 30
- Pages
- e1704490-e1704490
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2808401691
- Cited by
- 232
- References
- 52
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 23 · 2023: 29 · 2022: 33 · 2021: 41 · 2020: 34 · 2019: 41 · 2018: 7
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (51621002, 51572083, 51461165202, 51472085)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
- Keywords
- nitric oxide delivery, nitric oxide donors, glutathione S-transferase pi, glutathione-responsive release, redox-responsive drug release, anticancer drug delivery, cancer therapy
- MeSH terms
- Humans, Neoplasms, Nitric Oxide, Oxidation-Reduction, Tissue Distribution, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.